TrialJournal of lipid research2017

Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial.

Charlotte Koopal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.